Indore SEZ exports jump 32 pc due to increased orders from pharma units

Exports from Indore’s Special Economic Zone (SEZ) jumped 32 percent to Rs 8,127.67 crore during the first seven months of the current financial year due to increased orders from pharmaceutical units, an official said on Monday.

According to an official from the Union Ministry of Commerce and Industry, the Indore SEZ, which houses factories manufacturing various products, exported Rs 8,127.67 crore from April-October in the current financial year.

He said in the previous financial year, exports from this SEZ from April to October were worth Rs 6,157.11 crore.

“About 70 percent of exports from the Indore SEZ are pharmaceuticals, and the United States is among the top importers of these drugs,” the official said.

He said the Indore SEZ, spread over 572 hectares in the Pithampur Industrial Area, houses 59 plants in various sectors, including pharmaceuticals, packaging materials, engineering, textile manufacturing, and food processing. Of these, 22 are in the pharmaceutical sector alone.

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation